Cargando…
Engineering of small-molecule lipidic prodrugs as novel nanomedicines for enhanced drug delivery
A widely established prodrug strategy can effectively optimize the unappealing properties of therapeutic agents in cancer treatment. Among them, lipidic prodrugs extremely uplift the physicochemical properties, site-specificity, and antitumor activities of therapeutic agents while reducing systemic...
Autores principales: | Huang, Lingling, Yang, Jianmiao, Wang, Tiantian, Gao, Jianqing, Xu, Donghang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785568/ https://www.ncbi.nlm.nih.gov/pubmed/35073914 http://dx.doi.org/10.1186/s12951-022-01257-4 |
Ejemplares similares
-
Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020) -
Stimuli-responsive prodrug-based cancer nanomedicine
por: Xie, Angel, et al.
Publicado: (2020) -
Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations
por: Wang, Hangxiang, et al.
Publicado: (2017) -
Computational Prodrug Design Methodology for Liposome
Formulability Enhancement of Small-Molecule APIs
por: Balouch, Martin, et al.
Publicado: (2023) -
Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery
por: Wang, Sheng, et al.
Publicado: (2020)